Search

everythinglearnresearchcommunity

for

Search:↓

A new mutation in the FLCN gene linked to Birt-Hogg-Dube syndrome was found, suggesting people with certain lung collapse should be tested for this mutation and screened for kidney and colon cancer.

A new, efficient method has been developed to detect darolutamide and thalidomide, drugs used for certain hair loss and prostate cancer treatments, in pharmaceuticals and body fluids.

Always consider xanthomatous hypophysitis before deciding on pituitary surgery.

DPCP may be safe for treating alopecia during pregnancy, but more research is needed.

A new syndrome was linked to two new genetic changes in the MBTPS1 gene in a 14-year-old girl.

LMWP-PDGFA shows promise for improving hair health and treating hair loss with fewer side effects.

Recombinant thrombomodulin can effectively treat severe complications in Cronkhite-Canada syndrome.

Truncated LTBP-1 disrupts TGF-beta signaling, affecting hair growth.

Low oxygen levels affect the behavior of certain proteins in human skin cells.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Diphenylcyclopropenone is effective and safe for treating severe alopecia areata in children, with maintenance therapy reducing relapse risk.

Combining PEMF with PBST is more effective for hair regrowth than PBST alone.

Finasteride may reduce prostate cancer risk.

PRP injections may slightly improve testicular development in male lambs.

rPanglaoDB helps study rare cell types by merging RNA data, confirming fibrocytes' role in healing.

Bifidobacterium longum BB536 metabolites may help treat hair loss by repairing and promoting hair cell growth.

Dihydrotestosterone affects hair growth by changing the Wnt/β-catenin pathway, with low levels helping and high levels hindering growth.

Bisphenol-A (BPA) increases connections between brain cells and boosts their activity, but it blocks the effects of a male hormone on brain cell plasticity.

PDGF-D boosts stem cell growth and movement, enhancing hair regeneration.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

PTHrP and its receptor can control blood vessel growth and hair development in mouse skin.

Prostaglandin D2 blocks new hair growth after skin injury through the Gpr44 receptor.

PM-9 and finasteride effectively inhibit the enzyme that converts testosterone to DHT.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair growth cells and aiding self-repair.

Overexpression of PTHrP in chondrocytes causes short-limbed dwarfism and delayed bone formation in mice.

Finasteride before TURP reduces blood loss and improves early postoperative quality of life.

DNA methylation affects BMP7 gene expression, influencing cell growth in Hu sheep.

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

Dutasteride protects dopamine neurons in Parkinson's mice, but Finasteride doesn't.

Dormant melanoma cells in mice interact minimally with memory T cells due to a suppressive tumor environment.